USP <1790> Visual Inspection of Injections is the informational chapter of the United States Pharmacopeia that explains how to design, run and keep under control the visual inspection of injectable products: from the 100% inspection flow to AQL sampling, from defect classification to inspector qualification. It is the operational companion of USP <790> "Visible Particulates in Injections", which sets the official requirement. For anyone working in sterile manufacturing, QA or QC, mastering this pair of chapters means being ready for one of the areas FDA and EMA inspectors probe hardest: visible particles, container defects and avoidable recalls.
USP <1790> and USP <790>: two chapters, two roles
The first thing to clarify is the hierarchy. USP <790>, numbered below 1000, is a requirement chapter: it states that every unit of injectable product in its final container must be visually inspected and that the batch must be "essentially free" of visible particulates. USP <1790>, numbered above 1000, is an informational chapter: it adds no obligations, but describes the good practices used to meet the existing ones. The chapter started as a draft in Pharmacopeial Forum 41(1) in 2015 and is now part of the USP-NF, structured in eight sections: scope, introduction, typical inspection process flow, inspection life-cycle, interpretation of results, inspection methods and technologies, qualification and validation of inspection processes, conclusions and references.
The scope covers manual, semi-automated and fully automated inspection of parenterals, with a focus on extraneous visible particles — reliably detectable roughly above 50 µm — but also on container-closure defects: glass cracks, poorly seated stoppers, crimping defects that can compromise the sterile barrier.
100% inspection: the conditions that make the difference
The core of the process is the individual inspection of every filled unit. The standardized conditions set by USP <790> and discussed in <1790> are precise: illumination between 2,000 and 3,750 lux at the inspection point, white and black backgrounds in sequence, a gentle swirl or inversion to set any particles in motion, and an observation time of about 5 seconds per background, so about 10 seconds per container. For difficult containers — amber glass, opaque plastics, lyophilized products — the chapter suggests additional measures, such as increasing illumination up to about 10,000 lux or inspecting against the light from the back of the container.
These numbers are not a laboratory detail: they are the first thing an inspector checks on the shop floor, because non-compliant inspection conditions invalidate the entire documentation chain downstream. EU GMP Annex 1 (2022) likewise requires 100% individual inspection of filled containers of sterile products and management of the defects found within the quality system.
Visual inspection is one of those topics where pharmacopoeias, EU GMP and FDA guidance constantly intersect. If you want a weekly, practical, no-frills update on these regulatory crossroads, subscribe to The Pragmatic GMP, our free newsletter: five minutes a week to stay audit-ready.
AQL and interpretation of results
100% inspection is not infallible: the probability of detecting a particle depends on its size, color, density and on the container itself. That is why, after 100% inspection, USP <790> calls for a statistical verification on a sample using recognized sampling plans — ANSI/ASQ Z1.4 or ISO 2859 — with an AQL of 0.65% for visible particulates. USP <1790> develops this logic in the interpretation of results: define in a procedure the sampling plan, the acceptance criteria and the actions if the criteria are exceeded, including re-inspection and root-cause investigation.
The table summarizes how the roles are split between the two chapters:
| Aspect | USP <790> | USP <1790> |
|---|---|---|
| Nature | Requirement (chapter below 1000) | Informational guidance (chapter above 1000) |
| Main content | 100% inspection, standard conditions, "essentially free" standard | Inspection life-cycle, technologies, process qualification |
| Sampling | AQL 0.65% verification (ANSI/ASQ Z1.4 / ISO 2859) | Interpretation criteria, re-inspection and trend management |
| Defects covered | Visible particulates | Particles and container-closure defects, classified by criticality |
| Personnel | Inspection by qualified personnel | Qualification, requalification and inspector performance monitoring |
Classifying particles and defects: the basis of trending
USP <1790> distinguishes three categories of particulate matter that steer the investigation: inherent particles, expected and linked to the nature of the product (typical of suspensions and some proteins); intrinsic particles, originating from the process or product-contact materials (glass, rubber, stainless steel, gaskets); and extrinsic particles, foreign to the process (fibers, hair, insects) and always a sign of a contamination-control breach. On the defect side, the consolidated practice reflected in the chapter is classification by criticality: critical defects that compromise sterility or safety, major defects affecting functionality, minor cosmetic defects. Each class needs acceptance limits, per-batch and over-time trending, and alert thresholds that trigger an investigation before the problem becomes systemic.
Inspector qualification and the inspection life-cycle
No visual inspection process is defensible without qualified inspectors. The chapter requires normal or corrected visual acuity and color perception, verified periodically, training with representative defect sets and requalification at defined intervals. For process qualification and method comparison — for example between manual inspection and an automated machine — the reference is the Knapp test, which compares detection probabilities on the same units. The life-cycle is completed by threshold studies, which determine the smallest particle size reliably detectable under the site's real inspection conditions, and by continuous performance monitoring through AQL results and reject rates.
GuideGxP recommendation
If you need to set up or strengthen your site's visual inspection program, work in this order:
- Verify the physical conditions of the inspection station: lux measured and recorded, compliant backgrounds, inspection times respected in real practice, not just in the SOP.
- Formalize defect classification in an illustrated defect catalog shared by Production, QA and QC, with criticality class and associated action.
- Align the post-inspection AQL plan with ANSI/ASQ Z1.4 or ISO 2859 and define in a procedure what happens when the sample fails.
- Build realistic qualification sets (true defects from your own process, not just commercial standards) and track each inspector's performance.
- Bring the data into trending: reject rates by defect class, line and format, discussed periodically in quality review.
Since visual inspection of sterile products lives within the Annex 1 framework — from the CCS to container-defect management — you may find our operational guide EU GMP Annex 1 (2022): the complete map useful: it maps the requirements of the European text into concrete, audit-ready actions for the manufacturing site.
